G-W7K9HBSZ9E google-site-verification=0lV03ZaaYlPJ19oOujeuRuaa4MouRBN_E7hROmtPtKU

Myc Luciferase Reporter Lentivirus | 78628

(No reviews yet) Write a Review
SKU:
412-78628
Weight:
1.00 KGS
€1,707.00
Frequently bought together:

Description

Myc Luciferase Reporter Lentivirus | 78628 | Gentaur US, UK & Europe Disrtribition

Category: Cell Signaling/Lentivirus

Application: • Screen for activators or inhibitors of Myc signaling pathway in transduced target cells • Generate Myc Luciferase Reporter stable cell line (puromycin resistant)

Background: The Myc signaling pathway plays an important role in cell proliferation, differentiation, transformation and apoptosis. c-Myc is a transcription factor that heterodimerizes with Max to regulate Myc signaling pathway-responsive genes. Genetic alterations in MYC have been linked to a number of human cancers, including Burkitt's lymphoma, cervical, ovarian, breast, lung and pancreatic carcinomas. Thus, Myc is a promising therapeutic target for cancer treatment. Myc can be activated by the Wnt/β-catenin pathway.

Description: The Myc Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the Myc response element located upstream of the minimal TATA promoter and an antibiotic selection gene (puromycin) for the selection of stable clones. After transduction, the Myc signaling pathway in the target cells can be monitored by measuring the luciferase activity.

Product Type: Lentivirus

Shippement Condition: -80°C

View AllClose